| 000 | 01659 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515103705.0 | ||
| 264 | 0 | _c20080512 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.M708362200 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHook, Vivian Y H | |
| 245 | 0 | 0 |
_aInhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cMar 2008 |
||
| 300 |
_a7745-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 |
_aAmyloid Precursor Protein Secretases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAmyloid beta-Protein Precursor _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCathepsin B _xgenetics |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aDipeptides _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aMaze Learning _xdrug effects |
| 650 | 0 | 4 |
_aMemory _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 700 | 1 | _aKindy, Mark | |
| 700 | 1 | _aHook, Gregory | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 283 _gno. 12 _gp. 7745-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M708362200 _zAvailable from publisher's website |
| 999 |
_c17694418 _d17694418 |
||